Quest Diagnostics Inc Payments to Acquire Equity Method Investments
Quest Diagnostics Inc (DGX) reported Payments to Acquire Equity Method Investments of $10.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-22.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2021-02-22
- Quest Diagnostics Inc payments to acquire equity method investments for the quarter ending 2018-12-31 was $0.00.
- Quest Diagnostics Inc payments to acquire equity method investments for the quarter ending 2018-06-30 was $10.00M.
- Quest Diagnostics Inc payments to acquire equity method investments for the quarter ending 2016-12-31 was $0.00.
- Quest Diagnostics Inc payments to acquire equity method investments for the quarter ending 2015-12-31 was -$4.00M.
- Quest Diagnostics Inc payments to acquire equity method investments for fiscal 2018 was $10.00M.
- Quest Diagnostics Inc payments to acquire equity method investments for fiscal 2017 was $0.00.
- Quest Diagnostics Inc payments to acquire equity method investments for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Quest Diagnostics Inc payments to acquire equity method investments for fiscal 2015 was $33.00M.
| Period end | Payments to Acquire Equity Method Investments 3 month | Payments to Acquire Equity Method Investments 9 month | Payments to Acquire Equity Method Investments 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $10.00M 10-K · filed 2021-02-22 | |
| 2018-09-30 | $10.00M 10-Q · filed 2018-10-24 | ||
| 2018-06-30 | $10.00M 10-Q · filed 2018-07-25 | ||
| 2017-12-31 | $0.00 10-K · filed 2018-02-23 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $0.00 10-K · filed 2018-02-23 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-10-21 | ||
| 2015-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $33.00M 10-K · filed 2018-02-23 | |
| 2015-09-30 | $37.00M 10-Q · filed 2016-10-21 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $0.00 10-K · filed 2017-02-22 | |
| 2014-09-30 | $0.00 10-Q · filed 2015-10-29 | ||
| 2013-12-31 | $0.00 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |